We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sanofi | EU:SAN | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-0.36 | -0.35% | 103.36 | 102.74 | 103.70 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
103.70 | 100.40 | 100.74 | 2,066,340 | 16:40:00 |
Date | Time | Source | Headline |
---|---|---|---|
07/2/2025 | 06:00 | UKREG | Press Release: Execution of a share buyback agreement for up to €2 billion |
07/2/2025 | 06:00 | UKREG | Communiqué de presse : Sanofi annonce la signature d’un mandat de rachat.. |
03/2/2025 | 06:30 | UKREG | Press Release: Sanofi announces buy back of shares from L’Oréal |
03/2/2025 | 06:30 | UKREG | Communiqué de presse : Sanofi annonce un rachat d'actions à L'Oréal |
30/1/2025 | 06:30 | UKREG | Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance.. |
30/1/2025 | 06:30 | UKREG | Communiqué de presse : Croissance des ventes de 10,3% au T4. Objectif du.. |
29/1/2025 | 22:13 | UKREG | Sanofi: Information concerning the total number of voting rights and shares.. |
29/1/2025 | 22:13 | UKREG | Sanofi: Informations relatives au nombre de droits de vote et d'actions -.. |
22/1/2025 | 06:00 | UKREG | Communiqué de presse : Approbation du Sarclisa dans l’UE – premier.. |
22/1/2025 | 06:00 | UKREG | Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy.. |
1 Year Sanofi Chart |
Intraday Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions